Transforming Substance Use Disorder Treatment

Nomi Health takes a holistic, personalized approach to address the challenges of Substance Use Disorder today. Our program, Success Care, is patient-centric, providing holistic, comprehensive, and integrated care to your community or state.

Program Overview

The US is in the midst of an opioid overdose epidemic, with drug overdose continuing to be a leading cause of death in the United States. Communities are struggling, as 2.7 million people have a Substance Use Disorder (SUD). Our Success Care program is designed to provide holistic, comprehensive SUD care by bridging clinical services and social services for individuals and communities nationwide.

Our Services

Through our program, Success Care, we collaborate and integrate with like-minded change-makers to provide hyper-local, streamlined, and patient-centered solutions for Substance Use Disorder. The program includes:
1-1 Peer Support
Clinical Services (Medication assisted treatment, counseling, therapy, pharmacy, preventative and diagnostic testing)
Social Services Support & Navigation (community education, local resource navigation including digital and health literacy, SDoH).
Population Analytics and Insights
Integrated data warehouse and analytics
Interested in our patient-facing program?

Care Delivery Infrastructure

We believe everyone should have easy access to quality care. We meet patients where they are, both figuratively on their healthcare journey and literally in their neighborhood or at home, to support them every step of the way. We provide both clinical and social care and deliver these services through a multimodal approach, so no one falls through the cracks. This includes:
Success Care In-Person Clinics
Virtual Care
On-Site partnerships with existing provider community
Mobile Care Units

Life-Saving Care

We’re simplifying Naloxone access - an opioid-overdose reversal medication. Our non-stigmatizing online ordering platform bypasses traditional pharmacy hurdles, ensuring the nationwide availability of this essential medication.
Easy Access
Life-Saving Medication
Available Nationwide
Interested in ordering Naloxone?

Success Care Advisory Board

Dr. Ali Khan

Dean of the College of Public Health
Dr. Ali Khan is the Dean of the College of Public Health at the University of Nebraska Medical Center and former Assistant Surgeon General and Director of the Office of Public Health Preparedness and Response at Centers for Disease Control and Prevention. He is a tenured Professor in the Department of Epidemiology and has an extensive background focused on emerging infectious diseases and global health security.
Connect on LinkedIn

Solome Tibebu

Founder and CEO of Behavioral Health Tech
Solome Tibebu is the founder and CEO of Behavioral Health Tech, the largest community dedicated to advancing access to mental health and substance use services through technology, health equity and innovation. Previously, Tibebu was founding director of The Upswing Fund for Adolescent Mental Health. Through The Upswing Fund, Tibebu and her team funded over 100 community-based organizations and nonprofits nationwide focused on supporting the mental health of LGBTQ+ teens and adolescents of color.
Connect on LinkedIn

Andrey Ostrovsky, MD

Managing Partner at Social Innovation Ventures
The former chief medical officer of the U.S. Medicaid program, Dr. Ostrovsky is now the managing partner at Social Innovation Ventures, where he invests in and advises companies and nonprofits dedicated to eliminating health disparities. Dr. Ostrovsky currently teaches faculty and is an attending physician at Children's National Medical Center and has been outspoken about the death of his uncle, who died of a drug overdose at 45.
Connect on LinkedIn

Rich Bagger

Partner and Executive Director of Christie 55 Solutions
Rich Bagger is a Partner and Executive Director of Christie 55 Solutions, a New Jersey based consulting firm. Previously, Bagger worked in the health sector for over 25 years and in public service as Chief of Staff for New Jersey Governor Chris Christie, a member of the New Jersey General Assembly, a New Jersey State Senator, and Mayor of Westfield, New Jersey.
Connect on LinkedIn

Kevin Lynch

Founder and CEO of TheQuell Foundation
Kevin Lynch is the founder and CEO of The Quell Foundation, which aims to reduce the number of suicides, drug overdoses and incarceration of people living with a mental illness. As his twelve-year career in the elite United States Naval Submarine Force ended, Kevin moved into the healthcare industry to continue his commitment of caring and fighting for others. The Quell Foundation’s scholarship program has increased from 16 scholarships in 2016 to over 1,800 scholarships today, distributing over $3.2 million in awards to students attending over 480 different colleges and universities in all fifty states.
Connect on LinkedIn

Get In Touch Today

We work with local and state governments, organizations, and their partners to redesign Substance Use Disorder solutions for community wellbeing. Our Success Care program focuses on implementing comprehensive, personalized care. The current solutions are disjointed, leaving gaps in care where people need it most. Our program aims to fill those gaps, integrate existing solutions, and foster healthy communities.

Frequently Asked Questions

More questions? We’ve got answers.
Q.
Who can refer patients?
Q.
How & where can Nomi’s solutions be accessed?
Q.
Who can pay for Nomi’s services and how?

Here for You and Your Communities


Nomi Health is creating a cohesive approach for payers, at-risk hospitals, and employers across our complex care populations. For those populations that are often underserved and overlooked, we use a patient-centered approach to bring quality care to communities. Our services and solutions offered are fundamentally changing the way care is delivered, purchased, and paid for. Nomi's trusted operational experience during the Covid-19 response combined with our direct healthcare infrastructure is bringing patients and their care teams closer together.